Nucleoside

Results: 353



#Item
261AIDS InfoNet  www.aidsinfonet.org Fact Sheet Number 001A

AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 001A

Add to Reading List

Source URL: www.aidsinfonet.org

Language: English - Date: 2013-09-05 09:42:15
262Organic chemistry / Gilead Sciences / Organofluorides / Cyclopropanes / Non-nucleoside reverse transcriptase inhibitors / Antiretroviral drug / Reverse-transcriptase inhibitor / Emtricitabine / AIDS / HIV/AIDS / Chemistry / Medicine

AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 001A

Add to Reading List

Source URL: www.aidsinfonet.org

Language: English - Date: 2013-09-05 09:42:15
263The United States President’s Emergency Plan for AIDS Relief Bringing Hope: Supplying Antiretroviral Drugs for HIV/AIDS Treatment

The United States President’s Emergency Plan for AIDS Relief Bringing Hope: Supplying Antiretroviral Drugs for HIV/AIDS Treatment

Add to Reading List

Source URL: www.state.gov

Language: English - Date: 2014-08-02 19:44:55
264January 5, [removed]Vol[removed]Nos. 51 &[removed]Serious Adverse Events Attributed to Nevirapine Regimens for Postexposure Prophylaxis After HIV Exposures — Worldwide, 1997–2000

January 5, [removed]Vol[removed]Nos. 51 &[removed]Serious Adverse Events Attributed to Nevirapine Regimens for Postexposure Prophylaxis After HIV Exposures — Worldwide, 1997–2000

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2001-08-06 10:02:32
265ADAGEN® 	 (pegademase bovine) Injection DESCRIPTION

ADAGEN® (pegademase bovine) Injection DESCRIPTION

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-06-10 15:35:42
266Managing Drug Interactions in the Treatment of  HIV-Related Tuberculosis National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination

Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2013-10-30 10:15:46
267Please note: An erratum has been published for this issue. To view the erratum, please click here.  Morbidity and Mortality Weekly Report Recommendations and Reports  November 22, [removed]Vol[removed]No. RR-18

Please note: An erratum has been published for this issue. To view the erratum, please click here. Morbidity and Mortality Weekly Report Recommendations and Reports November 22, [removed]Vol[removed]No. RR-18

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2002-11-27 11:42:19
268HIV Resistance Collaborative  Group Data Analysis Plan for Resistance

HIV Resistance Collaborative Group Data Analysis Plan for Resistance

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 1999-10-29 04:20:00
2691  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EDURANT safely and effectively. See full prescribing information for EDURANT.

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EDURANT safely and effectively. See full prescribing information for EDURANT.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-05-20 11:23:31
270HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA.  •

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. •

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-06-10 15:35:43